SPA PHARMA MOISTURIZER CREAM SPF 50- homosalate, octisalate, octocrylene, avobenzone, titanium dioxide cream cream
Peer Pharm Ltd.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Moisturizer Cream SPF 50
Octinoxate 7.5%
Octocrylene 5%
Octisalate 5%
Avobenzone 3%
Homosalate 10%
Titanium Dioxide 3%
Keep out of reach of children.
Provides SPF 50 protection.
To Use: Smooth onto face.
For Sunscreen Use: Apply liberally 15 minutes before sun exposure. Reapply at least every 2 hours.
Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: Limit time in the sun, especially from 10 a.m. - 2 p.m. Wear long-sleeve shirts, pants, hats, and sunglasses.
Water, Polyglyceryl-10 Pentastearate & Behenyl Alcohol & Sodium Stearoyl Lactylate, Propylene Glycol, Cetyl Alcohol, Potassium Cetyl Phosphate, Dimethicone, Nylon-12, Dehydroacetic Acid & Benzoic Acid & Benzyl Alcohol, *Fragrance, Aloe Barbadensis (Aloe) Leaf Juice, Allantoin, Citric Acid, Tocopherol & Lecithin & Ascorbyl Palmitate & Glyceryl Stearate & Glyceryl Oleate.
For external use only.
Do not use on damaged or broken skin.
When using this product, keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs.
SPA PHARMA MOISTURIZER CREAM SPF 50
homosalate, octisalate, octocrylene, avobenzone, titanium dioxide cream cream |
Product Information |
Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC: 69435-1602 |
Route of Administration | TOPICAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) | TITANIUM DIOXIDE | 3 g in 100 mL |
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) | OCTOCRYLENE | 5 g in 100 mL |
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) | OCTISALATE | 5 g in 100 mL |
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) | OCTINOXATE | 7.5 g in 100 mL |
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) | AVOBENZONE | 3 g in 100 mL |
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) | HOMOSALATE | 10 g in 100 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 69435-1602-1 | 80 mL in 1 CONTAINER; Type 0: Not a Combination Product | 03/24/2016 | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph final | part352 | 03/24/2016 | 08/14/2019 |
|
Labeler - Peer Pharm Ltd.
(514678390)
|
Registrant - Peer Pharm Ltd. (514678390) |
Establishment |
Name | Address | ID/FEI | Business Operations |
Peer Pharm Ltd. | | 514678390 | manufacture(69435-1602) |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.